Stay updated on VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Sign up to get notified when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.

Latest updates to the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedAdded B-cell chronic lymphocytic leukemia as a condition term on the study page.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check30 days agoChange DetectedFooter revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.2 was added, and the preceding funding-status notice as well as Revision: v3.4.1 were removed. These appear to be site-wide maintenance updates and do not alter the study details.SummaryDifference0.4%

- Check66 days agoChange DetectedA site-wide notice about a lapse in government funding and that the NIH Clinical Center is open has been added, along with a revision update from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedShow glossary option added and study record metadata updated to revision v3.4.0. Minor capitalization and phrasing adjustments were made to QC criteria and FEAR Act data labels.SummaryDifference0.2%

Stay in the know with updates to VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VIP152 for Relapsed CLL or Richter Syndrome Clinical Trial page.